• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Apr 12;13:817345.
doi: 10.3389/fimmu.2022.817345. eCollection 2022.
Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray


Sina Hosseinian[SUP] 1 [/SUP], Kathleen Powers[SUP] 1 [/SUP], Milind Vasudev[SUP] 1 [/SUP], Anton M Palma[SUP] 2 [/SUP], Rafael de Assis[SUP] 3 [/SUP], Aarti Jain[SUP] 3 [/SUP], Peter Horvath[SUP] 2 [/SUP], Paramveer S Birring[SUP] 1 [/SUP], Rana Andary[SUP] 1 [/SUP], Connie Au[SUP] 1 [/SUP], Brandon Chin[SUP] 1 [/SUP], Ghali Khalil[SUP] 1 [/SUP], Jenny Ventura[SUP] 1 [/SUP], Madeleine K Luu[SUP] 4 [/SUP], Cesar Figueroa[SUP] 5 [/SUP], Joshua M Obiero[SUP] 3 [/SUP], Emily Silzel[SUP] 3 [/SUP], Rie Nakajima[SUP] 3 [/SUP], William Thomas Gombrich[SUP] 4 [/SUP], Algis Jasinskas[SUP] 3 [/SUP], Frank Zaldivar[SUP] 2 6 [/SUP], Sebastian Schubl[SUP] 1 5 [/SUP], Philip L Felgner[SUP] 3 [/SUP], Saahir Khan[SUP] 7 [/SUP], Specimen Collection Group



Affiliations

Abstract

Recent studies provide conflicting evidence on the persistence of SARS-CoV-2 immunity induced by mRNA vaccines. Here, we aim to quantify the persistence of humoral immunity following vaccination using a coronavirus antigen microarray that includes 10 SARS-CoV-2 antigens. In a prospective longitudinal cohort of 240 healthcare workers, composite SARS-CoV-2 IgG antibody levels did not wane significantly over a 6-month study period. In the subset of the study population previously exposed to SARS-CoV-2 based on seropositivity for nucleocapsid antibodies, higher composite anti-spike IgG levels were measured before the vaccine but no significant difference from unexposed individuals was observed at 6 months. Age, vaccine type, or worker role did not significantly impact composite IgG levels, although non-significant trends towards lower antibody levels in older participants and higher antibody levels with Moderna vaccine were observed at 6 months. A small subset of our cohort were classified as having waning antibody titers at 6 months, and these individuals were less likely to work in patient care roles and more likely to have prior exposure to SARS-CoV-2.

Keywords: SARS-CoV-2; antibodies; healthcare workers; mRNA; microarray; serology; vaccine.
 
Back
Top Bottom